// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Cartilage injury suppresses endogenous retinoic acid through activation of TGFβ-activated kinase 1 (TAK1)

L. Zhu - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

SB431542

JNK-dependent modulation of the protease secretome profile of osteoarthritic cartilage

H.M. Ismail - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Wound healing factor IL1α: a plausible trigger for zinc-mediated cartilage erosion?

W. Thompson - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Osteosarcoma

N/A

The gate to controlling chondrogenic differentiation: transcriptional regulation by SOX9 in ATDC5 cells

M.M. Caron - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Inhibition of interleukin-17-induced effects in osteoarthritis - an in vitro study

J.Y. Mimpen - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

Interleukin

Piezo1 expression is increased in response to non-invasive impact of mouse knee joint

R.C. Jones - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Age-related changes in micrornas expression in mouse cruciate ligaments

Y. Ashraf Kharaz - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The difference in synovitis (synovial membrane) and angiogenesis between young obese, young lean and old lean people with primary knee osteoarthritis

M. Al Mutani - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Neutrophil extracellular vesicles have a cartilage protective effect during inflammatory arthritis

B.L. Thomas - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Markers associated with synovial inflammation can identify women at high risk of developing painful radiographic knee osteoarthritis: a prospective community based cohort

S. Kluzek - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Knee osteoarthritis

N/A

Characterisation of synovial fluid cells of early osteoarthritis patients

J.K. Garcia - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Ex vivo inhibition of JAK and IKK preserves cartilage formation in catabolically stimulated bovine articular cartilage

C.S. Thudium - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tasocitinib

The synovial secretome contributes to cartilage pathology in osteoarthritis: a role for exosomes

S. Asghar - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Mesenchymal stem cells in chronic joint inflammation

L. Zaripova - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A new strategy for autologous chondrocyte implantation: autologous mesenchymal stem cell and chondrocyte implantation "first in man" study

J. Wang - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

stannous fluoride

The role of GCP-2 in cartilage differentiation and repair

M. Alvarez Fallas - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Development of functional nanoparticles for MSC-targeted joint repair in situ

M. Walker - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Wnt signalling in mesenchymal stem cells is heightened in response to plasma sprayed hydroxyapatite coatings

D. Kuntin - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Assessing the characteristics of human mesenchymal stromal cells derived from bone marrow and umbilical cord following expansion in the quantum® hollow-fibre bioreactor system

C. Mennan - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pulsed electromagnetic fields enhance metabolic activity and myotube formation in an in vitro model of myoblasts

F.F. Masieri - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Proglumide

Copyright © 2026. QuantiNova All rights reserved